Efficacy and Safety of Single-port Surgical Robot System in Thoraic Surgery

Inclusion criteria

• Age between 18 and 75 years, regardless of gender.
• Patients who require endoscopic surgical treatment and have indications for lung segment/lobe resection; for pre-trial subjects, there is no restriction on the type of procedure, and inclusion is based on the investigator's judgment of having indications for thoracic surgery.
• Preoperative ASA classification of I-III.
• Voluntary participation in the clinical trial and willingness to provide informed.

consent, either by the subject or their guardian.

• Willingness to cooperate and complete trial follow-up and related examinations.

Exclusion criteria

• Patients with a history of thoracic surgery or previous history of other malignant tumors deemed unsuitable for inclusion by the investigator.
• Patients with severe comorbidities (cardiac, pulmonary, hepatic, cerebral, renal diseases) or physical weakness who cannot tolerate general anesthesia or surgery.
• Patients with severe bleeding tendencies or coagulation disorders.
• Patients in the active phase of infectious diseases or with other severe non-communicable infections.
• Patients positive for Human Immunodeficiency Virus (HIV) antibodies or syphilis seropositive patients.
• Patients with a suspected or confirmed alcohol, drug, or substance addiction.
• Patients with a history of epilepsy, mental illness, or cognitive impairment.
• Women who are pregnant, breastfeeding, or planning to become pregnant during the trial period.
• Participation in other interventional clinical trials within 3 months prior to signing the informed consent form.
• Other situations in which the investigator deems inappropriate for participation in this clinical trial.